CBPO [China Biologic Products] SC 13G/A: (Original Filing)

[1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Capital World Investors ** 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware 5 SOLE VOTING POWER 770,953 6 SHARED VOTING]

CBPO [China Biologic Products] SC 13G/A: 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS.

[1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Capital World Investors ** 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware 5 SOLE VOTING POWER 770,953 6 SHARED VOTING]

CBPO [China Biologic Products] SC 13G/A: 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS.

[1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Capital World Investors ** 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware 5 SOLE VOTING POWER 770,953 6 SHARED VOTING]

CBPO [China Biologic Products] 8-K: FOR RELEASE May 3, 2017 China Biologic Reports

[FOR RELEASE May 3, 2017 China Biologic Reports Financial Results for the First Quarter of 2017 -- 1Q17 Total Sales Up 6.9% YoY to $91.5Million and Net Income Up 14.5% YoY to $30.0 Million in USD terms, or Total Sales Up 12.7% YoY and Non-GAAP Adjusted Net Income Up 29.7% YoY in RMB terms-- --Reitera]

CBPO [China Biologic Products] 10-Q: (Original Filing)

[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the state]

CBPO [China Biologic Products] 10-Q:

[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the state]

CBPO [China Biologic Products] 8-K: (Original Filing)

[FOR RELEASE May 3, 2017 China Biologic Reports Financial Results for the First Quarter of 2017 -- 1Q17 Total Sales Up 6.9% YoY to $91.5Million and Net Income Up 14.5% YoY to $30.0 Million in USD terms, or Total Sales Up 12.7% YoY and Non-GAAP Adjusted Net Income Up 29.7% YoY in RMB terms-- --Reitera]

CBPO [China Biologic Products] 8-K: (Original Filing)

[AGREEMENT AND PLAN OF MERGER Agreement CBPO CBPO Cayman This AGREEMENT AND PLAN OF MERGER (this “ RECITALS Merger 1. The Boards of Directors of each of CBPO and CBPO Cayman have unanimously determined that it is advisable and in the best interests of their respective shareholders or stockholders to ]

CBPO [China Biologic Products] 8-K: AGREEMENT AND PLAN OF MERGER Agreement CBPO CBPO

[AGREEMENT AND PLAN OF MERGER Agreement CBPO CBPO Cayman This AGREEMENT AND PLAN OF MERGER (this “ RECITALS Merger 1. The Boards of Directors of each of CBPO and CBPO Cayman have unanimously determined that it is advisable and in the best interests of their respective shareholders or stockholders to ]

CBPO [China Biologic Products] 10-K/A: (Original Filing)

[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this Amendment No.1 to the Annual Report on Form 10-K of China Biologic Products, Inc.; and 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact nece]

Skip to toolbar